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Objectives: The study aimed to examine whether food addiction (FA) was
associated with greater severity in both binge eating disorders (BED) and
bulimia nervosa and, therefore, to determine if FA was predictive of treatment
outcome.
Method: Seventy‐one adult patients with bulimia nervosa and BED (42 and
29, respectively) participated in the study. FA was assessed by means of the
Yale Food Addiction Scale.
Results: The results confirmed a high prevalence of FA in patients with binge
disorders (around 87%) and also its association with a greater severity of the dis-
order (i.e., related to an increased eating psychopathology and greater fre-
quency of binge eating episodes). Although FA did not appear as a predictor
of treatment outcome in general terms, when the diagnostic subtypes were con-
sidered separately, FA was associated with poor prognosis in the BED group. In
this vein, FA appeared as a mediator in the relationship between ED severity
and treatment outcome.
Discussions: Our findings suggest that FA may act as an indicator of ED
severity, and it would be a predictor of treatment outcome in BED but not in
BN.t authorship.
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Food addiction (FA) is a controversial construct that has
not been recognized as a diagnostic entity so far.
However, FA is receiving an increased interest and a
growing body of research in the last years (Fernández‐
Aranda, 2018). The concept of FA posits that individuals
experience addictive‐like symptoms related to the con-
sumption of high‐calorie/palatable foods (Bonder, Davis,
Kuk, & Loxton, 2018; Davis, 2016; Meule, von Rezori, &
Blechert, 2014; such as preoccupation with obtaining a
desired food, excessive consumption of unhealthy foods
despite adverse health consequences, craving, impaired
control, tolerance, withdrawal, and distress/dysfunction;
Fletcher & Kenny, 2018; Gordon, Ariel‐Donges,
Bauman, & Merlo, 2018), and with biological–hormonal
maintaining factors (Novelle & Diéguez, 2018; Peters
et al., 2018). It has been related to other addictive disor-
ders due to the parallels in the neurochemistry
(Gearhardt 2016; Jiménez‐Murcia et al., 2017; Tomasi
et al., 2015), specifically in terms of participation of
the dopaminergic reward system and the activation of
positive reinforcement mechanisms (Carter & Davis,
2011; Racine, Hagan, & Schell, 2019; Volkow, Wang,
Fowler, Tomasi, & Baler, 2012). This evidence suggests
that FA could be evaluated by considering the behav-
ioural and symptomatology patterns observed in other
addictions, as captured in the Yale Food Addiction Scale
(YFAS; Gearhardt, Corbin, & Brownell, 2009). Neverthe-
less, the debate about FA vs. eating addiction vs.
nonaddiction remains open (Meule, 2019). Although
some researchers have postulated for an integration of
FA into substance use disorders (Gordon et al., 2018),
others argue that it would be within behavioural addic-
tions (Albayrak, Wölfle, & Hebebrand, 2012). On the
other hand, other studies even doubt about the existence
of underlying addictive processes and postulate the loss
of control overeating as a core symptom of the eating
disorder (ED; Fletcher & Kenny, 2018).
Despite FA has not yet been formally recognized by
the Diagnostic and Statistical Manual for Mental Disor-
ders (DSM‐5; APA, 2013), it has emerged as a clinical
entity recognized within the spectrum of obesity and
abnormal eating behaviour (Wiss & Brewerton, 2017).
Recent studies have shown a high prevalence of FA
among patients with obesity and/or with an ED, espe-
cially among those with binge eating symptomatology
(Granero et al., 2014; Granero et al., 2018; Wiss &Brewerton, 2017). Thus, studies on ED have found a
high prevalence of FA in patients with bulimia nervosa
(BN; de Vries & Meule, 2016; Granero et al., 2018;
Meule et al., 2014) and binge eating disorder (BED;
Gearhardt, Boswell, & White, 2014; Penzenstadler et al.
2018; Smith and Robbins 2013), reaching rates ranging
from 70% to 90% (Granero et al., 2014). In addition,
FA has also been associated with higher eating‐related
severity and psychopathology (Granero et al., 2014;
Imperatori et al., 2014), especially with greater levels
of weight/shape overvaluation and body dissatisfaction,
an increased frequency of binge eating episodes (Bur-
rows, Hides, Brown, Dayas, & Kay‐Lambkin, 2017; Bur-
rows, Kay‐Lambkin, Pursey, Skinner, & Dayas, 2018), as
well as with more dysfunctional personality traits (Wolz
et al., 2016) and emotional regulation deficits (Carlson
et al., 2018).
The literature analysing FA and response to treat-
ment is very scarce, and results are not yet conclusive.
The few studies assessing the relationship between FA
and treatment outcome in ED have focused on brief
interventions for patients with BN (Hilker et al., 2016)
or on a food‐specific inhibition training for patients with
BED (Giel, Speer, Schag, Leehr, & Zipfel, 2017). In this
vein, Hilker et al. (2016) found that severity of FA was
a short‐term predictor of abstinence from
binging/purging episodes after a brief psychoeducational
therapy among patients with BN (Hilker et al., 2016).
However, other study applying food‐specific inhibition
training in patients with BED found that this interven-
tion improved the inhibitory control towards high‐
caloric food stimuli, but it was not able to produce
changes in food craving or FA in these patients (Giel
et al., 2017). Additionally, the findings regarding FA
and weight loss interventions in patients with obesity
are still controversial. Although some authors found
that FA may act as a predictor of less weight loss after
a low‐calorie dietetic intervention (Guerrero Pérez
et al., 2018), others have shown that the presence of
FA before surgery was not associated with presurgical
body mass index (BMI) neither postoperative weight loss
(Ivezaj, Wiedemann, & Grilo, 2017). Furthermore, some
studies have revealed that the weight loss induced by a
low‐calorie diet (Guzzardi et al., 2018) or by bariatric
surgery (Murray, Tweardy, Geliebter, & Avena, 2019;
Pepino, Stein, Eagon and Klein, 2014; Sevinçer, Konuk,
Bozkurt and Coşkun, 2016) induced remission of FA
702 ROMERO ET AL.symptoms and improved several dietary behaviours
associated with FA.
Thus, on the basis of the available evidence
abovementioned, we hypothesized that FA may act as an
indirect measure of ED psychopathology and, therefore, it
may be associated with poorer treatment outcome in
patients with binge disorder, namely BN or BED. There-
fore, and taking into account all the aforementioned gaps
in the literature, the specific aims of the study were (a) to
analyse whether the presence of FA is associated with
greater ED psychopathology in the different binge diagno-
ses (BN and BED) and (b) to analyse whether the presence
of FA is associated with poor treatment outcome in
patients with binge disorder, namely BN and BED, after
an outpatient cognitive‐behavioural therapy (CBT)
intervention.2 | METHODS
2.1 | Participants and procedureSample composed of 71 adult patients diagnosed with
binge disorders (42 BN and 29 BED), who were consecu-
tive referrals to the Eating Disorders Unit at Bellvitge
University Hospital in Barcelona. ED diagnoses were
made by means of a face‐to‐face semistructured clinical
interview (Fernández‐Aranda & Turón, 1998) that has
been updated based on the validated SCID‐5 interview
(First, Williams, Karg, & Spitzer, 2015) and conducted
by experienced clinical psychologists and psychiatrists.
The inclusion criteria for the sample were as follows: (a)
18 years and older, (b) diagnosed with BN or BED accord-
ing to DSM‐5 criteria; (DSM‐5; APA, 2013), and (c) have
completed a structured outpatient CBT group. Patients
who dropped out the treatment were excluded from the
present study (no statistical differences were found in
the comparison between patients who completed and
dropped out the CBT intervention, nor for the presence
of a FA positive screening score [P = .100], nor for the
FA severity level [p = .443], nor for the ED severity level
[p = .519], nor for the age of onset of the ED [p = .279],
nor for the duration of the disorder [P = .235], and nei-
ther for the disorder subtype [p = .766]) .
The present study was approved by the Ethics Com-
mittee of our institution (the Ethics Committee of Clinical
Research of the Bellvitge University Hospital), and all
research was conducted in accordance with the latest ver-
sion of the Helsinki Declaration. Signed informed consent
was provided by all participants.2.2 | Assessment
Information about current ED symptoms, antecedents,
and other psychopathological data of interest, as well as
other relevant sociodemographic and clinical variables,
were obtained by a face‐to‐face, standardized, structured
interview. Additionally, the following commonly applied
questionnaires in the field of EDs were employed:
• Eating Disorders Inventory‐2 (EDI‐2; Garner, 1991).
The Spanish validation of this questionnaire has been
used (Garner, 1998) to assess psychological and behav-
ioural characteristics of the ED. The internal consis-
tency (coefficient alpha) for the current sample was
excellent (α = .94).
• YFAS (Gearhardt et al., 2009; Spanish validation
(Granero et al., 2014). This is a 25‐item self‐report
instrument that was designed to assess FA according
to the seven symptoms of substance dependence listed
in the Diagnostic and Statistical Manual of Mental Dis-
orders 4th edition Text Revision. When at least three
criteria and significant clinical impairment are
reported, a diagnosis of FA is given. Moreover, a symp-
tom count, indicating FA severity, can be measured to
provide a score between 1 and 7. The internal consis-
tency of our sample was good (α = .84).2.3 | Treatment
Treatment for BN and BED consisted of 16 weekly outpa-
tient group therapy conducted by experienced psycholo-
gist. Patients with BN and BED were placed in
separated therapy groups, but both treatment groups were
based on the same CBT programme. The treatment proto-
col was manualized and published in Spanish
(Fernández‐Aranda & Turón, 1998). Its effectiveness has
been described previously (Agüera et al., 2013).
Patients were reassessed at discharge and categorized
into the following three categories: full remission, partial
remission, and nonremission. These categories were
based on the consensus judgment of the senior clinical
staff who considered all aspects of the patient's treatment
outcome, such as frequency of binge episodes and com-
pensatory behaviours (such as self‐induced vomiting or
laxative and diuretics misuse), and improvement in ED
cognitions. To assess clinical significance of response to
treatment, the therapists had access to objective primary
measures, such as the number of binging/purging epi-
sodes per week, based on entries from a food diary.
According to DSM‐5 criteria (APA, 2013), the working
definition of full remission was a total absence of
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consecutive weeks, partial remission was defined as sub-
stantial symptomatic improvement but with residual
symptoms, and the patients who presented poor out-
comes were defined as nonremission. These categories
were previously used to assess treatment outcome in
threshold ED in other published studies (Agüera et al.,
2015; Agüera et al., 2017; Custal et al., 2014; Sauchelli
et al., 2016; Steward et al., 2016).2.4 | Statistical analysis
Statistical analysis was carried out with Stata16 for win-
dows. Partial correlations adjusted by sex and age esti-
mated the association between the FA severity level with
the other eating clinical variables (EDI‐2 scores, BMI and
frequency of binge eating episodes). In this analysis and
due the strong association between statistical significance
for the R‐coefficients and sample size (low‐poor coeffi-
cients tend to achieve statistical significance estimated into
large samples, whereas high coefficients tend to nonstatis-
tical significant into samples with a few number of partici-
pants), effect size was considered low‐poor for |R| > .10,
moderate‐medium for |R| > .24 and large‐high for |
R| > .37 (these thresholds corresponds to Cohen's d of
0.20, 0.50, and 0.80, respectively (Rosnow & Rosenthal,
1996).
Logistic regression assessed the contribution of the
participant's age, the diagnostic subtype (BED vs. BN),
the ED severity (EDI‐2 total score), and the presence of
FA (present vs. absent) on the likelihood of a CBT poor
treatment outcome (defined as nonremission). Fitting of
the model was valued with the Hosmer–Lemeshow test
(goodness‐of‐fit was considered for p > .05); global predic-
tive capacity was measured with the Nagelkerke's
pseudo‐R2 coefficient, and global discriminative ability
with the area under the ROC curve (AUC; effect size for
AUC< .65 was interpreted as low‐poor, for.65 <AUC< .70
moderate‐medium, and for AUC > .70 large‐high;
Steyerberg et al., 2001).
Path analysis procedures modelled as a case of struc-
tural equation modelling (SEM) estimated the underlying
mechanism (including mediational links, direct, and indi-
rect effects) between the participants' age, the diagnostic
subtype, the FA severity, and the ED severity on the likeli-
hood of the CBT treatment outcome. In this work, the
maximum‐likelihood estimationmethod of parameter esti-
mation was defined and fitting was tested through stan-
dard statistical measures: the chi‐square test (χ2), the root
mean square error of approximation (RMSEA), Bentler's
Comparative Fit Index (CFI), the Tucker–Lewis Index
(TLI), and the standardized root mean square residual(SRMR). Adequate goodness‐of‐fit was considered for
(Barrett, 2007): P > .05 in the (χ2), RMSEA<.08, TLI > .90,
CFI > .90, and SRMR<.10. The global predictive capacity of
the model was measured by the coefficient of determina-
tion (CD). Themodel was obtained for the women subsam-
ple (n = 61) because the low frequency of men in the
sample did not allow fitting.
3 | RESULTS
3.1 | Characteristics of the sample
Most of the participants were women (n = 62, 87.3%) and
single (n = 41, 57.5%). Participants in the BN group were
younger (mean = 30.6 years old, SD = 10.0) compared
with participants with BED (mean = 39.3 years old,
SD = 9.9; p = .001), and the onset of the ED was also at
an early age in the BN group (mean = 19.1 years old
[SD = 6.6] versus mean = 25.2 years old [SD = 11.3],
p = .006). No differences between the groups emerged
for the duration of the disorder (mean = 11.3 years
[SD = 10.7] versus mean = 15.3 years [SD = 9.8],
p = .111). Table S1 includes the description for all the
measures of the study and the comparison between the
ED subtypes (BN vs. BED).3.2 | Comparison of the FA measures
between sexes
All men in the study met clinical criteria, according to
YFAS, for a positive screening score in the FA measure,
and n= 54 (87.1%)women also reported positive screening.
However, the comparison of the difference was statistically
nonsignificant (p= .128, but this result must be interpreted
with caution due the small sample size), but effect size was
into the moderate‐medium range (|d| = 0.54). Further-
more, the number of total DSM criteria for FA was higher
for women (mean = 5.7, SD = 1.3) compared with men
(mean = 5.1, SD = 1.2; although the mean difference was
statistically nonsignificant [p = .182], the effect size was
into the moderate‐medium range [|d| = 0.51]).3.3 | Association of the FA severity with
ED measures
Table S2 includes the association between FA severity
(number of FA criteria) and the EDI‐2 scales (bulimia
and impulse regulation scales and the total score), BMI,
and frequency of binge eating episodes (partial correla-
tions adjusted by sex and age). When considering the total
sample, a positive correlation between the FA and the















704 ROMERO ET AL.psychopathology (measured by EDI‐2) was found. Into
the BN group, FA level positively correlated with ED psy-
chopathology (specifically with EDI‐2 bulimia and total
scores), BMI, and weekly frequency of binge eating epi-
sodes. For patients with BED, FA severity also positively
correlated with the ED psychopathology and with the












Full remission 62.5% 57.1% .882 0.11 40.0% 4
Partial remiss. 25.0% 33.3% 0.18 40.0% 4
Nonremission 12.5% 9.5% 0.10 20.0% 1
Note. Bold: effect size into the moderate‐medium (|d| > 0.50) to large‐high range (
Abbreviations: BED, binge eating disorder; BN, bulimia nervosa; BED, binge eating
food addiction.
*Significant comparison (.05 level).3.4 | Baseline FA and therapy outcome
among the ED subtypes
Table 1 displayed the percentage of patients with or with-
out FA at baseline according to each therapy outcome cat-
egory (full remission, partial remission, and
nonremission) among the ED subtypes (Figure 1 includes
the bar chart with the linear showing linear/quadraticamong ED subtypes
BED
es




n = 26 p |d|
0.5% .826 0.01 100% 80.8% .444 0.69*
8.6% 0.17 0% 11.5% 0.51*
0.8% 0.26 0% 7.7% 0.41
|d| > 0.80).
disorder; |d|: Cohen's d coefficient (absolute value) ED, eating disorder; FA
FIGURE 1 Bar‐chart for the percentage
of participants in each therapy outcome
condition (full remission, partial
remission, and nonremission; n = 71).
Note. FA, food addiction; BN, bulimia
nervosa; BED, binge eating disorder. Blue
colour line, linear/quadratic trend for the
FA = no condition. Red colour line,
linear/quadratic trend for FA = yes
condition [Colour figure can be viewed at
wileyonlinelibrary.com],
ROMERO ET AL. 705trends). Whereas no differences between the groups were
obtained in the resulting therapy outcome categories
when considering the total sample and the BN subsam-
ple, there were significant differences obtained in the
BED group. Namely, the participants with BED with
baseline positive FA presented poorer treatment outcome
than those with baseline negative FA (80.8% vs. 100% full
remission, respectively).3.5 | Predictive model of the therapy
outcome
Table 2 contains the final logistic regression, when con-
sidered the whole sample (BN and BED), for the criterion
therapy outcome “nonremission,” considering as predic-
tors the participants' age, diagnostic type, ED psychopa-
thology (measured by means of EDI‐2 total score), and
presence of FA (positive vs. negative screening score).
No significant interaction was found between the FA
and the age (p = 0.347), suggesting that the effect of the
FA on the therapy outcome was equal independent of
the participants' age. The results of the model including
the interaction parameter show that the risk of a poor
therapy outcome is increased for older patients and those
with a higher ED psychopathology at baseline. No predic-
tive capacity on the therapy result was obtained for the
diagnostic subtype and the FA. The model achieved goodABLE 2 Predictive capacity of FA level on the poor outcome (nonremission): Logistic regression (n = 71)
Coefficients Fitting
B SE p OR 95% CI (OR) R2 AUC H‐L
Age (years) 0.106 0.049 .013* 1.11 1.01 1.22 .225 .833 .715
Diagnosis (0 = BN; 1 = BED) −1.651 1.007 .073 0.19 0.03 1.38
ED severity (EDI‐2 total) 0.022 0.013 .045* 1.02 1.01 1.05
FA (0 = negative; 1 = positive) −2.070 1.465 .164 0.13 0.01 2.23
Interaction FA‐by‐age Parameter excluded due the non‐significant result: p = .347
bbreviations: AUC, area under ROC curve; BED, binge eating disorder; BN, bulimia nervosa; ED, eating disorder; FA, food addiction; H‐L, Hosmer–Lemeshow
st (p value); R2, Nagelkerke's pseudo R2.
Significant parameter (.05 level).





fitting (Hosmer–Lemeshow: p = .715), large‐high predic-
tive capacity (R2 = .225) and large‐high discriminative
ability (AUC = 0.833).3.6 | Pathways analysis (SEM)
Figure 2 contains the path diagram with the standardized
coefficients obtained in the SEM (complete results are in
Table S3). The model only retained the significant coeffi-
cients, and adequate goodness‐of‐fit was obtained:
χ2 = 1.27 (p = .259), RMSEA = 0.067, CFI = 0.993,
TLI = 0.935, and SRMR = 0.031. The results of the model
showed that BED diagnosis and lower ED severity
achieved direct effect on the CBT outcome, increasing
the likelihood of full remission. Two mediational links
also emerged: (a) older age was related to both lower
ED severity levels and presence of BED diagnosis, which
increased the risk of good outcome, and (b) lower FA
severity were related to lower levels in the ED severity,
which increased the odds of full remission. The global
predictive capacity of the SEM was CD = 0.366.4 | DISCUSSION
Although the interest in studying the association between
FA and ED has increased drastically in the last few years,
most of the published studies have used cross‐sectional
706 ROMERO ET AL.designs (Fernandez‐Aranda, Karwautz, & Treasure,
2018). One of the few studies analysing FA as a possible
predictor of treatment outcome in patients with bulimic
symptoms was carried out after a brief psychoeducational
intervention (Hilker et al., 2016), and only the short‐term
effect was assessed. Hence, to our knowledge, this is the
first study that attempted to address whether the presence
of FA is associated with greater ED psychopathology and
treatment outcome after a completed CBT outpatient
programme.
First, as expected, this study confirmed previous find-
ings on the high prevalence of FA in patients with BN
(de Vries & Meule, 2016; Meule et al., 2014) and BED
(Gearhardt et al., 2014; Smith & Robbins, 2013;
Penzenstadler et al., 2018). Similar to previous studies
(Granero et al., 2014), we found that about 87% of female
patients with bulimic symptoms scored positive in the
YFAS (Granero et al., 2014; Wiss & Brewerton, 2017).
Males with ED even had higher rates of FA than their
female counterparts. These results are in disagreement
with another study that indicated a higher prevalence of
FA in women than in men (Hauck, Weiß, Schulte, Meule,
& Ellrott, 2017). This inconsistency might be explained by
the fact that our study assessed patients with ED, whereas
the study of Hauck et al. (2017) analysed FA in the gen-
eral population. Therefore, our findings may be slightly
inflated because of increased severity of eating‐related
symptoms in males with EDs. However, these results
should be interpreted with caution due the small sample
size of the males with ED's.
Second, the main finding of our study confirms the
association between FA and the ED psychopathology.
Patients with FA, both BN and BED, scored higher in
the EDI‐2 questionnaire and presented more weekly fre-
quency of binge eating behaviours. These results are in
line with previous literature that reported a direct associ-
ation between FA, bingeing ED subtype and with greater
eating and psychopathological severity (Granero et al.,
2014). Some authors have even suggested that FA may
be solely a marker of severity especially associated with
factors such as more frequent binge eating episodes (Bur-
rows et al., 2017; Burrows et al., 2018; Imperatori et al.,
2014) and that FA does not independently measure addic-
tive mechanisms (Granero et al., 2014; Hilker et al., 2016;
Ivezaj, Wiedemann, Lydecker, & Grilo, 2018). In addition,
our results were not able to find significant differences
between the presence of FA and BMI in ED, solely in
those with BN. Hence, as suggested in previous studies
(Villarejo et al., 2014), BMI may be a consequence of
disinhibited eating behaviour rather than a factor related
to FA itself. In ED patients, FA may not predict disor-
dered eating behaviour indiscriminately, but it might bespecifically linked to disinhibited eating (Burgess, Turan,
Lokken, Morse, & Boggiano, 2014).
Third, and partially supporting our hypothesis, our
findings showed a direct association between the pres-
ence of FA and a poor clinical outcome in BED but
not in BN or in the sample of ED as a whole. We found
that the presence of FA in the subsample of patients
with BED was associated with a lower likelihood of
achieving full remission. Overall, patients with BED
tend to show a better prognosis than patients with BN
(Agüera et al., 2013; Linardon, Kothe, & Fuller‐
Tyszkiewicz, 2019). However, this finding suggests that
the presence of FA in patients with BED might be act-
ing as a maintenance factor for binge eating episodes,
possibly due to its effect on the impaired reward system
characteristic of addictive processes. The extent to which
patients with BED can benefit from approaches and
interventions based on an addictive model should be
elucidated in further studies.
In terms of clinical predictors, our results showed an
association between ED psychopathology and CBT out-
come: The higher the ED psychopathology, the lower
the probability of ED symptomatological remission.
These results are in accordance with previous literature
(Dakanalis, Colmegna, Riva, & Clerici, 2017; Lammers,
Vroling, Ouwens, Engels, & van Strien, 2015; Vroling,
Wiersma, Lammers, & Noorthoorn, 2016; Wagner
et al., 2015) reporting that ED psychopathology, such
as binge eating episodes and shape/weight concerns,
are significant predictors of dropout, and high levels of
body dissatisfaction are associated with poor outcomes.
In addition, our results also showed that age played an
important role in the prognosis of these disorders. In
line with previous studies, our results evidenced that
younger patients presented with higher ED psychopa-
thology (Agüera et al., 2017). Contrastingly, our findings
indicated an association between older age and higher
YFAS scores. These results are not in line with a previ-
ous research reporting that the younger population
exhibited a higher prevalence of FA (Hauck et al.,
2017). However, these discrepancies may be due to the
fact that the study of Hauck et al. (2017) analysed peo-
ple in the general population, whereas we assessed
patients with binge disorders. Therefore, in our sample,
older patients with binge disorders may be those with
a longer duration of the disorder and increased FA
symptomology (Hauck et al., 2017).
Finally, one of the most striking findings of our study
was that FA per se was not directly associated with the
response to treatment. These findings are not in accor-
dance with a prior study reporting that FA severity is a
short‐term predictor of abstinence from binging/purging
ROMERO ET AL. 707episodes in patients with BN after a brief group treatment
(Hilker et al., 2016). However, although we were not able
to find a direct effect of FA on the treatment outcome, FA
seems to act as a mediator in the relationship between ED
psychopathology (measured by the total EDI‐2 score) and
treatment outcome. In this sense, FA may act as a marker
of the severity of the ED and, therefore, is the severity of
the disorder (increased and impaired by the FA), rather
than the presence of FA for itself, which acts as a predic-
tor of nonremission.4.1 | Limitations and strengths
Some limitations must be taken into account when
interpreting the results of this study. First, we used the
first version of YFAS (Gearhardt et al., 2009) that was
developed to operationalize indicators of addictive‐like
eating, originally based on the Diagnostic and Statistical
Manual of Mental Disorders 4th edition Text Revision
criteria for substance‐use disorders. However, it would
be useful to replicate the results using the updated version
of this scale (i.e., YFAS 2.0). The YFAS 2.0 was developed
to reflect changes to diagnostic criteria in the DSM‐5
(Gearhardt, Corbin, & Brownell, 2016). Second, the lim-
ited sample size and especially the lack of males in the
sample do not allow us to generalize the results. Third,
the present study did not use the same standardized ques-
tionnaires at the end of the treatment (as objective mea-
sures), which would have contributed to the reliability
and objectivity of our longitudinal findings. Finally, we
were not able to analyse the presence of FA before the
disorder, so we cannot confirm that FA came prior to
the ED and, therefore, acts as a risk factor for the severity
of the ED or, on the contrary, a greater severity of the dis-
ease causes greater FA presence, as a marker of severity.
Notwithstanding these limitations, the current study
also has several strengths that should be noted. As far as
we know, this is the first study assessing whether FA
may act as a possible predictor of treatment outcome in
patients with BN and BED. Also, the findings derived
from this study might improve our ability to better under-
stand the influence of FA in the prognosis of these
patients and thereby aid in tailoring the best treatment
alternatives.5 | CLINICAL IMPLICATIONS
In the light of these findings, FA might be interpreted as a
severity index of the ED indirectly associated with treat-
ment outcome. Therefore, it would be necessary to deter-
mine which therapeutic tools might be effective for the
treatment of FA, especially in patients with BED. In thissense, further studies are needed to assess the extent to
which patients with BED can benefit from other
approaches and interventions based on the addictive
model to improve treatment outcomes (Meule, 2019).
However, it is a controversial point because, despite the
neurobiological and clinical similarities between FA and
addictive disorders, the consumption of food (unlike alco-
hol, substances, or gambling) is necessary for life, making
it impossible to design a treatment based on total
abstinence.6 | CONCLUSIONS
In conclusion, our findings confirm the high presence of
FA in a clinical sample of EDs, concretely in bingeing
ED subtypes. Our results also indicate that high FA levels
were associated with greater ED psychopathology in
patients with BED and BN. The presence of FA was found
as a predictor of treatment outcome just in the case of
BED but not in BN. Finally, the results suggest that FA
may act as a marker of severity and, therefore, also as a
mediator between ED severity and treatment outcome,
especially for patients with BED.CONFLICT OF INTEREST
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